Year All202620252024202320222021202020192018201720162014201320112010 April 6, 2023 Rhythm Pharmaceuticals Announces New Employment Inducement Grants March 27, 2023 Rhythm Pharmaceuticals Announces Publication of Bardet-Biedl Syndrome Patient and Caregiver Perspectives of Hunger and Quality of Life with Setmelanotide March 6, 2023 Rhythm Pharmaceuticals Announces New Employment Inducement Grants March 1, 2023 Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results February 27, 2023 Rhythm Pharmaceuticals Announces Acquisition of Xinvento B.V. and Portfolio of Investigational Therapeutics February 21, 2023 Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 1, 2023 February 8, 2023 Rhythm Pharmaceuticals Announces New Employment Inducement Grants January 23, 2023 Rhythm Pharmaceuticals Announces Publication of Analysis of Quality of Life Improvements from Phase 3 Clinical Trial in Bardet-Biedl Syndrome January 5, 2023 Rhythm Pharmaceuticals Announces New Employment Inducement Grants December 7, 2022 Rhythm Pharmaceuticals Announces New Employment Inducement Grants
March 27, 2023 Rhythm Pharmaceuticals Announces Publication of Bardet-Biedl Syndrome Patient and Caregiver Perspectives of Hunger and Quality of Life with Setmelanotide
February 27, 2023 Rhythm Pharmaceuticals Announces Acquisition of Xinvento B.V. and Portfolio of Investigational Therapeutics
February 21, 2023 Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 1, 2023
January 23, 2023 Rhythm Pharmaceuticals Announces Publication of Analysis of Quality of Life Improvements from Phase 3 Clinical Trial in Bardet-Biedl Syndrome
